Busulfan 60mg/10mL (6mg/mL) Injection

Busulfan 60mg/10mL (6mg/mL) is an intravenous alkylating medicine used in conditioning regimens before haematopoietic stem-cell transplantation. Its transplant role differs from older low-dose oral busulfan treatment.
The concentrate is diluted and delivered by a controlled intravenous infusion, commonly over 2 hours in a divided-dose conditioning regimen. Anticonvulsant prophylaxis and antiemetic treatment are provided. Drug-exposure sampling may guide later doses. Other conditioning schedules use their own infusion plan.
Busulfan cross-links DNA and suppresses marrow cells, helping prepare the body for the planned stem-cell graft.
Profound marrow suppression, nausea, mouth inflammation, infection and liver toxicity can occur. Seizures, lung toxicity and hepatic sinusoidal obstruction syndrome are important serious risks.
Dose calculations and exposure monitoring account for weight, age and the regimen. Metronidazole and some antifungals can increase exposure.
Controlled marrow ablation and immune suppression help create conditions for engraftment of the transplanted cells.
Paracetamol can affect glutathione, a substance involved in clearing busulfan, and may increase busulfan exposure. Tell the transplant team when you last took it before using it for fever or pain during conditioning.
Busulfan can provoke seizures at conditioning exposure, so prophylaxis is planned before treatment.
It estimates total drug exposure over time, helping avoid both insufficient conditioning and excessive toxicity.
It can signal hepatic sinusoidal obstruction and fluid retention during transplant conditioning and needs urgent assessment.
Conditioning: treatment preparing for a stem-cell transplant. AUC: total drug exposure over time. Engraftment: establishment of transplanted blood-forming cells.; AR: Busulfan 60mg/10mL (6mg/mL) حقن; FR: Busulfan 60mg/10mL (6mg/mL) injection; PT: Busulfan 60mg/10mL (6mg/mL) injeção; ES: Busulfan 60mg/10mL (6mg/mL) inyección; RU: Busulfan 60mg/10mL (6mg/mL) инъекция; ID: Busulfan 60mg/10mL (6mg/mL) suntikan; VI: Busulfan 60mg/10mL (6mg/mL) thuốc tiêm; MS: Busulfan 60mg/10mL (6mg/mL) suntikan; TL: Busulfan 60mg/10mL (6mg/mL) iniksyon; ZH-SG: Busulfan 60mg/10mL (6mg/mL) 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Busulfan 60mg/10mL (6mg/mL) Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Busulfan 60mg/10mL (6mg/mL) Injection